Please login to the form below

Not currently logged in
Email:
Password:

Amgen announces 380 US job cuts

Amgen is to cut 380 R&D jobs in the US as the biotechnology company aims to streamline its operations

Amgen is to cut 380 R&D jobs in the US as the biotechnology company aims to streamline its operations.

Mary Klem, director of media relations at the company, said the job losses were "targeted and strategic", with no particular therapy area affected or sites to be shut down.

Jobs will go at research facilities in Thousand Oaks and San Francisco in California, as well as in Seattle and Massachusetts. Cuts are also expected in the UK.

Klem said: "We have lots of molecules moving into later stages of development, which means more expensive stages of development."

Amgen also announced former Bristol-Myers Squibb (BMS) senior vice president, commercial operations, Tony Hooper as the company's executive vice president, global commercial operations, effective October 26.

Hooper spent 16 years at BMS where his roles included running the BMS commercial business in North America, Asia, Middle East, Africa, South America and Europe.

He said: "It's a privilege to join Amgen, a company well-known for scientific innovation and developing life-changing therapies for people with serious illnesses."

20th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics